BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 11395387)

  • 1. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation.
    Fiano V; Ghimenti C; Imarisio S; Silengo L; Schiffer D
    Anticancer Res; 2004; 24(5A):2643-7. PubMed ID: 15517868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis.
    Eng C
    Ann N Y Acad Sci; 2002 Jun; 968():213-21. PubMed ID: 12119278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
    Weng LP; Brown JL; Eng C
    Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
    Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
    Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
    Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
    Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
    Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
    Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
    Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.
    Agrawal S; Pilarski R; Eng C
    Hum Mol Genet; 2005 Aug; 14(16):2459-68. PubMed ID: 16014636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
    Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.